Target intelligence / Profile preview

SSX family member 13, pseudogene (SSX13P)

Target
SSX13P
Molecular classification
Other (Pseudogene)
01

Overview

SSX family member 13, pseudogene (SSX13P) is classified as a pseudogene within the SSX gene family, which includes several protein-coding members involved in chromosomal translocations in synovial sarcoma (notably SSX1, SSX2, and rarely SSX4)[1][3][4]. Pseudogenes are DNA sequences similar to known genes but typically do not encode functional proteins due to mutations or lack of regulatory elements. The SSX13P gene does not appear to produce protein or exhibit any functional biological activity and is not implicated in human diseases or targeted by therapies[1]. Although SSX family genes are known for their role as cancer-testis antigens and in specific chromosomal translocations in synovial sarcoma, pseudogene members like SSX13P do not participate in these events. SSX13P may be used as a reference sequence in genomics studies but is not a valid drug or biomarker target[1][3][4]. SSX13P is a non-functional pseudogene with no protein product, biological function, or validated role in disease, drug targeting, or molecular therapy. Its nomenclature is correct, and there are no safety or clinical concerns associated with it as a molecular target[1].

Other names
psiSSX3SSXP3SSX family pseudogene 3SSX3 pseudogenesynovial sarcoma, X breakpoint 5 pseudogeneSSX13P

Beyond the preview

Go deeper on SSX family member 13, pseudogene (SSX13P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSX family member 13, pseudogene (SSX13P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call